Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy – Reuters

Written by

admin

in

  1. Rocket Pharmaceuticals withdraws US application for blood disorder gene therapy  Reuters
  2. Rocket drops FDA bid for Fanconi anaemia gene therapy  FirstWord Pharma
  3. Rocket Pharmaceuticals (RCKT) PT Lowered to $7 at Leerink Partners  StreetInsider
  4. Rocket withdraws FDA application for rare blood disorder gene therapy  Endpoints News
  5. Hold Rating on Rocket Pharmaceuticals Amid Strategic Shifts and Regulatory Challenges  TipRanks

Continue Reading

More posts